Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms

The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflammation can be more beneficial than targeting gene mutants. We evaluated the proinflammatory IL-6 cytokine and JAK-STAT signaling pathway related genes in circulating CD34(+) cells of MPNs. Regarding l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mediators Inflamm
Main Authors: Čokić, Vladan P., Mitrović-Ajtić, Olivera, Beleslin-Čokić, Bojana B., Marković, Dragana, Buač, Marijana, Diklić, Miloš, Kraguljac-Kurtović, Nada, Damjanović, Svetozar, Milenković, Pavle, Gotić, Mirjana, Raj, Puri K.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602333/
https://ncbi.nlm.nih.gov/pubmed/26491227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/453020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados